'Superpotent' Thyroid Drug Recall; 10% of Hospitalized COVID-19 Patients With Diabetes Die

<![CDATA[]]>(MedPage Today) — The FDA announced that Acella Pharmaceuticals issued a voluntary recall of 13 lots of the company’s 30-mg, 60-mg, and 90-mg NP Thyroid tablets for being “superpotent” — i.e., containing as much as 115% of the labeled amount…

Source link

Related posts

Preschool Is Prime Time to Teach Healthy Lifestyle Habits


Pioneering Gene Therapy by UCSF Benioff Children's Hospital Oakland Researchers Demonstrates Therapy Can Eliminate Life-Long Need for Transfusions in Patients with Incurable Blood Disorder


What Does an Influenza B Dominant Flu Season Mean?


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World